title: Von Willebrand Factor and ADAMTS13: Too Much or Too Little of a Good Thing?
authors.affiliation: From the Department of Internal Medicine (B.T.E., D.G.), Life Sciences Institute, Department of Human Genetics, Howard Hughes Medical Institute (D.G.), and Department of Pediatrics and Communicable Disease (D.G., K.C.D.), University of Michigan, Ann Arbor.
authors.forename: Brian T
authors.initials: BT
authors.lastname: Emmer
authors.affiliation: From the Department of Internal Medicine (B.T.E., D.G.), Life Sciences Institute, Department of Human Genetics, Howard Hughes Medical Institute (D.G.), and Department of Pediatrics and Communicable Disease (D.G., K.C.D.), University of Michigan, Ann Arbor.
authors.forename: David
authors.initials: D
authors.lastname: Ginsburg
authors.affiliation: From the Department of Internal Medicine (B.T.E., D.G.), Life Sciences Institute, Department of Human Genetics, Howard Hughes Medical Institute (D.G.), and Department of Pediatrics and Communicable Disease (D.G., K.C.D.), University of Michigan, Ann Arbor. ginsburg@umich.edu.
authors.forename: Karl C
authors.initials: KC
authors.lastname: Desch
mesh_terms: D000071120:ADAMTS13 Protein; D014841:von Willebrand Factor
chemical_list: D014841:von Willebrand Factor; D000071120:ADAMTS13 Protein
keywords: ADAM proteins; Editorial; Von Willebrand factor; cause of death; disintegrin; thrombospondins